Business
Nemaura Announces Completion of SugarBEAT® European Clinical Trial Programme and Positive Interim Results
Nemaura Announces Completion of SugarBEAT® European Clinical Trial Programme and Positive Interim Results.
About this update from Nemaura Medical, Inc.
[{"type":"text","content":"\n \n Nemaura Medical Inc. (“Nemaura”) (OTCQB: NMRD), a medical \n technology company developing the wireless sugarBEAT® disposable \n adhesive skin-patch as a non-invasive, affordable and flexible glucose \n monitoring system for adjunctive use by persons with diabetes, today \n announced the completion of its sugarBEAT® European clinical trial \n programme and positive interim accuracy data.\n \n \n The European clinical trial programme consisted of a total of 525 \n patient days, comprising 75 patients continuously wearing sugarBEAT® for \n up to 14 hours per day over 7 consecutive days in a combination of home \n and clinic settings. Interim results based on all 525 patient days have \n detected no instances of skin irritation or major adverse events \n resulting from the device. Interim accuracy results, taken from a cohort \n of 175 patient days, have indicated MARD as low as 10% over a large \n dynamic range, with average MARD comparable to accuracy previously \n achieved by the wired wrist-worn predecessor SugarBEAT® device, which \n received a CE mark in 2016.\n \n \n A summary of the full clinical report is due to be published next \n month alongside CE submission.\n \n \n SugarBEAT® consists of a disposable skin-patch connected to a \n rechargeable transmitter, with a mobile app displaying glucose readings \n at regular five minute intervals.\n \n \n Further clinical studies are planned including those for FDA approval in \n the US, and to investigate the use of sugarBEAT® in critical care \n settings.\n \n \n About Nemaura Medical, Inc.\n \n \n Nemaura Medical is a medical technology company developing sugarBEAT® as \n a non-invasive, affordable and flexible glucose monitoring system for \n adjunctive use by persons with diabetes. SugarBEAT® consists of a \n disposable skin-patch connected to a rechargeable transmitter, with a \n mobile app displaying glucose readings at regular five minute intervals. \n For more information, please visit www.nemauramedical.com \n and www.sugarbeat.com.\n \n \n Cautionary Statement Regarding Forward Looking Statements\n \n \n The statements in this press release that are not historical facts, and \n may consti...